[Federal Register Volume 79, Number 45 (Friday, March 7, 2014)]
[Notices]
[Pages 13053-13054]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2014-04970]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30 Day-14-14CL]


Agency Forms Undergoing Paperwork Reduction Act Review

    The Centers for Disease Control and Prevention (CDC) publishes a 
list of information collection requests under review by the Office of 
Management and Budget (OMB) in compliance with the Paperwork Reduction 
Act (44 U.S.C. Chapter 35). To request a copy of these requests, call 
(404) 639-7570 or send an email to [email protected]. Send written comments 
to CDC Desk Officer, Office of Management and Budget, Washington, DC 
20503 or by fax to (202) 395-5806. Written comments should be received 
within 30 days of this notice.

Proposed Project

    An Investigation of Lung Health at an Indium-Tin Oxide Production 
Facility--New--National Institute for Occupational Safety and Health 
(NIOSH), Centers for Disease Control and Prevention (CDC).

Background and Brief Description

    The mission of the National Institute for Occupational Safety and 
Health (NIOSH) is to promote safety and health at work for all people 
through research and prevention. The Occupational Safety and Health 
Act, Public Law 91-596 (section 20[a][1]), authorizes NIOSH to conduct 
research to advance the health and safety of workers. NIOSH is 
proposing to conduct a study regarding the lung health of workers at an 
indium-tin oxide production facility.
    Indium-tin oxide (ITO) is a sintered material used in the 
manufacture of devices such as liquid crystal displays, touch panels, 
solar cells, and architectural glass. Indium lung disease is a novel, 
potentially fatal industrial disease that has occurred in workers 
making, using, or recycling ITO. This project aims to understand and 
prevent this occupational lung disease by investigating the 
relationship between exposure and lung health among current ITO 
manufacturing workers.
    CDC requests Office of Management and Budget (OMB) approval to 
collect standardized information from current employees of the ITO 
production facility through an informed consent document, an 
interviewer-administered questionnaire, and a contact information form. 
As part of the same project, employees will be offered the opportunity 
to participate in medical testing and personal air sampling.
    The questionnaire will collect contact information, demographic 
information, respiratory symptoms and diagnoses, work history, and 
cigarette smoking history. The questionnaire will allow NIOSH to report 
individual medical test results to each participant and to analyze 
aggregate data from the workforce to determine risk factors for 
abnormal lung health indices derived from the medical test results. The 
individual results will be used by employees and their personal 
physicians to make medical decisions, such as whether to pursue 
additional testing. The aggregate results will be used by NIOSH, 
facility management, and employees in ongoing efforts to reduce 
exposures and monitor key health indices.
    For this study, we will recruit all current employees of the ITO 
production facility. Participation is voluntary. We anticipate 
approximately 100 study participants. Employees who wish to participate 
in the questionnaire and medical testing will review and sign an 
informed consent document. Employees who wish to participate in the 
personal air sampling and would like to receive personal results will 
complete a contact information form. Participants who wish to release 
medical records to NIOSH or to have NIOSH release the results of our 
medical testing to a personal physician will need to complete the 
appropriate records release forms.
    The questionnaire will be administered privately at the workplace 
during normal working hours by trained NIOSH staff. Employees who are 
not available at the workplace during the study will be offered the 
opportunity to respond to the questionnaire at a later date by 
telephone.
    There are no costs to participants other than their time.
    The total estimated burden for the one-time collection of data is 
254 hours.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                     Number of    Average burden
          Type of respondents                   Form name            Number of     responses per   per response
                                                                    respondents     respondent      (in hours)
----------------------------------------------------------------------------------------------------------------
Current ITO production facility         Recruitment letter......             100               1            5/60
 employees.
                                        Consent to participate                95               1           15/60
                                         in a research study.
                                        Authorization to                      95               1            5/60
                                         disclose health
                                         information.
                                        Indium facility                       95               1           20/60
                                         questionnaire.
                                        Medical testing.........              95               1          100/60
                                        Script for collection of              95               1            5/60
                                         industrial hygiene
                                         samples.
                                        Personal air sampling                 95               1            5/60
                                         results contact
                                         information form.
                                        Exposure monitoring.....              95               1            5/60
----------------------------------------------------------------------------------------------------------------



[[Page 13054]]

Leroy Richardson,
Chief, Information Collection Review Office, Office of Scientific 
Integrity, Office of the Associate Director for Science, Office of the 
Director, Centers for Disease Control and Prevention.
[FR Doc. 2014-04970 Filed 3-6-14; 8:45 am]
BILLING CODE 4163-18-P